Don't Just Swap The Engine. Redesign The Factory.

By Elena Filimonova, Chief Marketing Officer and Jagath Wanninayake, Chief Executive Officer

AI is rapidly moving from concept to capability in clinical research, reshaping how trials are designed, managed, and executed. In this conversation with Suvoda CEO Jagath Wanninayake, learn how AI-native clinical trial technology is accelerating study startup, streamlining trial operations, improving patient experiences, and enhancing supply management without compromising regulatory rigor.

From agentic RTSM that can compress study build timelines from months to weeks to Sofia, an AI-powered assistant that enables trial teams to access insights and execute complex workflows through natural language, Suvoda is rethinking clinical trial technology from the ground up. The discussion explores how AI can simplify user interactions and the critical role of domain expertise, transparency, and auditability in ensuring AI solutions meet the demanding standards of clinical research. Discover how sponsors, CROs, and technology providers can leverage AI to build more patient-centered trials while maintaining the trust and integrity that clinical development requires.